nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—CYP1A1—chronic obstructive pulmonary disease	0.8	1	CbGaD
Fluorescein—CYP1A1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00123	0.117	CbGpPWpGaD
Fluorescein—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000842	0.00443	CcSEcCtD
Fluorescein—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00081	0.00427	CcSEcCtD
Fluorescein—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000789	0.00416	CcSEcCtD
Fluorescein—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000778	0.0041	CcSEcCtD
Fluorescein—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000766	0.00403	CcSEcCtD
Fluorescein—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.004	CcSEcCtD
Fluorescein—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.000754	0.00397	CcSEcCtD
Fluorescein—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00392	CcSEcCtD
Fluorescein—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00389	CcSEcCtD
Fluorescein—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000738	0.00389	CcSEcCtD
Fluorescein—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.00386	CcSEcCtD
Fluorescein—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000732	0.00385	CcSEcCtD
Fluorescein—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000729	0.00384	CcSEcCtD
Fluorescein—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000729	0.00384	CcSEcCtD
Fluorescein—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000727	0.00383	CcSEcCtD
Fluorescein—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000721	0.0038	CcSEcCtD
Fluorescein—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000721	0.0038	CcSEcCtD
Fluorescein—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000719	0.00379	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000716	0.00377	CcSEcCtD
Fluorescein—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000716	0.00377	CcSEcCtD
Fluorescein—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000714	0.00376	CcSEcCtD
Fluorescein—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00071	0.00374	CcSEcCtD
Fluorescein—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00071	0.00374	CcSEcCtD
Fluorescein—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00071	0.00374	CcSEcCtD
Fluorescein—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00373	CcSEcCtD
Fluorescein—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00373	CcSEcCtD
Fluorescein—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000699	0.00368	CcSEcCtD
Fluorescein—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000695	0.00366	CcSEcCtD
Fluorescein—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00365	CcSEcCtD
Fluorescein—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000693	0.00365	CcSEcCtD
Fluorescein—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000693	0.00365	CcSEcCtD
Fluorescein—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000692	0.00364	CcSEcCtD
Fluorescein—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000689	0.00363	CcSEcCtD
Fluorescein—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000688	0.00363	CcSEcCtD
Fluorescein—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00361	CcSEcCtD
Fluorescein—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00068	0.00358	CcSEcCtD
Fluorescein—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000678	0.00357	CcSEcCtD
Fluorescein—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000675	0.00355	CcSEcCtD
Fluorescein—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000673	0.00354	CcSEcCtD
Fluorescein—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000672	0.00354	CcSEcCtD
Fluorescein—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00067	0.00353	CcSEcCtD
Fluorescein—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00067	0.00353	CcSEcCtD
Fluorescein—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00067	0.00353	CcSEcCtD
Fluorescein—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00352	CcSEcCtD
Fluorescein—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00351	CcSEcCtD
Fluorescein—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000653	0.00344	CcSEcCtD
Fluorescein—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00337	CcSEcCtD
Fluorescein—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00337	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000635	0.00335	CcSEcCtD
Fluorescein—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00334	CcSEcCtD
Fluorescein—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00334	CcSEcCtD
Fluorescein—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00333	CcSEcCtD
Fluorescein—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000628	0.00331	CcSEcCtD
Fluorescein—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000621	0.00327	CcSEcCtD
Fluorescein—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00325	CcSEcCtD
Fluorescein—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00325	CcSEcCtD
Fluorescein—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000605	0.00319	CcSEcCtD
Fluorescein—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0006	0.00316	CcSEcCtD
Fluorescein—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00316	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000597	0.00314	CcSEcCtD
Fluorescein—Cough—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00314	CcSEcCtD
Fluorescein—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00314	CcSEcCtD
Fluorescein—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00311	CcSEcCtD
Fluorescein—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00311	CcSEcCtD
Fluorescein—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000585	0.00308	CcSEcCtD
Fluorescein—Cough—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00308	CcSEcCtD
Fluorescein—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000583	0.00307	CcSEcCtD
Fluorescein—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00307	CcSEcCtD
Fluorescein—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00307	CcSEcCtD
Fluorescein—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00307	CcSEcCtD
Fluorescein—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00306	CcSEcCtD
Fluorescein—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00058	0.00305	CcSEcCtD
Fluorescein—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00305	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000578	0.00305	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.00305	CcSEcCtD
Fluorescein—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000575	0.00303	CcSEcCtD
Fluorescein—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000575	0.00303	CcSEcCtD
Fluorescein—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00299	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000566	0.00298	CcSEcCtD
Fluorescein—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00298	CcSEcCtD
Fluorescein—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00297	CcSEcCtD
Fluorescein—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000562	0.0532	CbGpPWpGaD
Fluorescein—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00294	CcSEcCtD
Fluorescein—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00294	CcSEcCtD
Fluorescein—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00294	CcSEcCtD
Fluorescein—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00294	CcSEcCtD
Fluorescein—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00294	CcSEcCtD
Fluorescein—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.0029	CcSEcCtD
Fluorescein—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000549	0.00289	CcSEcCtD
Fluorescein—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000548	0.00289	CcSEcCtD
Fluorescein—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.00288	CcSEcCtD
Fluorescein—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000547	0.00288	CcSEcCtD
Fluorescein—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000547	0.00288	CcSEcCtD
Fluorescein—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000547	0.00288	CcSEcCtD
Fluorescein—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000547	0.00288	CcSEcCtD
Fluorescein—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00287	CcSEcCtD
Fluorescein—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00287	CcSEcCtD
Fluorescein—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00286	CcSEcCtD
Fluorescein—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.00286	CcSEcCtD
Fluorescein—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00286	CcSEcCtD
Fluorescein—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00054	0.00285	CcSEcCtD
Fluorescein—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000536	0.00282	CcSEcCtD
Fluorescein—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000531	0.0028	CcSEcCtD
Fluorescein—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00278	CcSEcCtD
Fluorescein—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00278	CcSEcCtD
Fluorescein—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00275	CcSEcCtD
Fluorescein—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00275	CcSEcCtD
Fluorescein—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000519	0.00273	CcSEcCtD
Fluorescein—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00273	CcSEcCtD
Fluorescein—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000517	0.00272	CcSEcCtD
Fluorescein—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00272	CcSEcCtD
Fluorescein—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00271	CcSEcCtD
Fluorescein—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.0027	CcSEcCtD
Fluorescein—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000511	0.0484	CbGpPWpGaD
Fluorescein—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00051	0.00268	CcSEcCtD
Fluorescein—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00268	CcSEcCtD
Fluorescein—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000498	0.00262	CcSEcCtD
Fluorescein—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000498	0.00262	CcSEcCtD
Fluorescein—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00259	CcSEcCtD
Fluorescein—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000491	0.00259	CcSEcCtD
Fluorescein—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000489	0.00258	CcSEcCtD
Fluorescein—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000485	0.00255	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00254	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00254	CcSEcCtD
Fluorescein—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00251	CcSEcCtD
Fluorescein—Pain—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00251	CcSEcCtD
Fluorescein—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00249	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000472	0.00249	CcSEcCtD
Fluorescein—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00247	CcSEcCtD
Fluorescein—Pain—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00246	CcSEcCtD
Fluorescein—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000466	0.00246	CcSEcCtD
Fluorescein—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000462	0.00244	CcSEcCtD
Fluorescein—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000462	0.00243	CcSEcCtD
Fluorescein—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00242	CcSEcCtD
Fluorescein—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00242	CcSEcCtD
Fluorescein—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00242	CcSEcCtD
Fluorescein—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000457	0.00241	CcSEcCtD
Fluorescein—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.0024	CcSEcCtD
Fluorescein—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000456	0.0024	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.0024	CcSEcCtD
Fluorescein—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00237	CcSEcCtD
Fluorescein—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00235	CcSEcCtD
Fluorescein—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00234	CcSEcCtD
Fluorescein—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00234	CcSEcCtD
Fluorescein—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00232	CcSEcCtD
Fluorescein—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00232	CcSEcCtD
Fluorescein—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00044	0.00232	CcSEcCtD
Fluorescein—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.0023	CcSEcCtD
Fluorescein—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.00229	CcSEcCtD
Fluorescein—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00229	CcSEcCtD
Fluorescein—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00229	CcSEcCtD
Fluorescein—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00229	CcSEcCtD
Fluorescein—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00228	CcSEcCtD
Fluorescein—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000433	0.00228	CcSEcCtD
Fluorescein—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00228	CcSEcCtD
Fluorescein—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00227	CcSEcCtD
Fluorescein—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00224	CcSEcCtD
Fluorescein—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.0022	CcSEcCtD
Fluorescein—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00219	CcSEcCtD
Fluorescein—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00217	CcSEcCtD
Fluorescein—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00217	CcSEcCtD
Fluorescein—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00216	CcSEcCtD
Fluorescein—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00212	CcSEcCtD
Fluorescein—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00211	CcSEcCtD
Fluorescein—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00211	CcSEcCtD
Fluorescein—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00208	CcSEcCtD
Fluorescein—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00208	CcSEcCtD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.0374	CbGpPWpGaD
Fluorescein—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000392	0.00207	CcSEcCtD
Fluorescein—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00204	CcSEcCtD
Fluorescein—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000387	0.00204	CcSEcCtD
Fluorescein—CYP1A1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.0361	CbGpPWpGaD
Fluorescein—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00199	CcSEcCtD
Fluorescein—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00196	CcSEcCtD
Fluorescein—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00195	CcSEcCtD
Fluorescein—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00194	CcSEcCtD
Fluorescein—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00194	CcSEcCtD
Fluorescein—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000361	0.0019	CcSEcCtD
Fluorescein—CYP1A1—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.000356	0.0337	CbGpPWpGaD
Fluorescein—ABCB11—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.000356	0.0337	CbGpPWpGaD
Fluorescein—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00187	CcSEcCtD
Fluorescein—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00187	CcSEcCtD
Fluorescein—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00185	CcSEcCtD
Fluorescein—Rash—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00185	CcSEcCtD
Fluorescein—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00185	CcSEcCtD
Fluorescein—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00185	CcSEcCtD
Fluorescein—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.00184	CcSEcCtD
Fluorescein—Headache—Formoterol—chronic obstructive pulmonary disease	0.00035	0.00184	CcSEcCtD
Fluorescein—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00184	CcSEcCtD
Fluorescein—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00183	CcSEcCtD
Fluorescein—Rash—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00182	CcSEcCtD
Fluorescein—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00181	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.00181	CcSEcCtD
Fluorescein—Headache—Montelukast—chronic obstructive pulmonary disease	0.000342	0.0018	CcSEcCtD
Fluorescein—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00176	CcSEcCtD
Fluorescein—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00176	CcSEcCtD
Fluorescein—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00175	CcSEcCtD
Fluorescein—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00175	CcSEcCtD
Fluorescein—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00175	CcSEcCtD
Fluorescein—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00175	CcSEcCtD
Fluorescein—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00175	CcSEcCtD
Fluorescein—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00174	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.00171	CcSEcCtD
Fluorescein—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00171	CcSEcCtD
Fluorescein—CYP1A1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.0306	CbGpPWpGaD
Fluorescein—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00169	CcSEcCtD
Fluorescein—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00168	CcSEcCtD
Fluorescein—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00166	CcSEcCtD
Fluorescein—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00165	CcSEcCtD
Fluorescein—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.00164	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.00159	CcSEcCtD
Fluorescein—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.00159	CcSEcCtD
Fluorescein—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.00157	CcSEcCtD
Fluorescein—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00155	CcSEcCtD
Fluorescein—CYP1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000294	0.0278	CbGpPWpGaD
Fluorescein—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00154	CcSEcCtD
Fluorescein—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00148	CcSEcCtD
Fluorescein—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00147	CcSEcCtD
Fluorescein—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00143	CcSEcCtD
Fluorescein—CYP1A1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00027	0.0256	CbGpPWpGaD
Fluorescein—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00142	CcSEcCtD
Fluorescein—CYP1A1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.0246	CbGpPWpGaD
Fluorescein—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00136	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00132	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00131	CcSEcCtD
Fluorescein—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00128	CcSEcCtD
Fluorescein—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00127	CcSEcCtD
Fluorescein—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00126	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00125	CcSEcCtD
Fluorescein—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00123	CcSEcCtD
Fluorescein—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00122	CcSEcCtD
Fluorescein—CYP1A1—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000232	0.022	CbGpPWpGaD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000228	0.0012	CcSEcCtD
Fluorescein—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00119	CcSEcCtD
Fluorescein—CYP1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000225	0.0213	CbGpPWpGaD
Fluorescein—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.00117	CcSEcCtD
Fluorescein—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00116	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00116	CcSEcCtD
Fluorescein—ABCC1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.0206	CbGpPWpGaD
Fluorescein—Shock—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00114	CcSEcCtD
Fluorescein—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00113	CcSEcCtD
Fluorescein—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00113	CcSEcCtD
Fluorescein—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00112	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00112	CcSEcCtD
Fluorescein—CYP1A1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.019	CbGpPWpGaD
Fluorescein—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00105	CcSEcCtD
Fluorescein—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00104	CcSEcCtD
Fluorescein—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.001	CcSEcCtD
Fluorescein—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.001	CcSEcCtD
Fluorescein—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000997	CcSEcCtD
Fluorescein—ABCB11—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000186	0.0176	CbGpPWpGaD
Fluorescein—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000953	CcSEcCtD
Fluorescein—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000946	CcSEcCtD
Fluorescein—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000946	CcSEcCtD
Fluorescein—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000919	CcSEcCtD
Fluorescein—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000914	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000165	0.0156	CbGpPWpGaD
Fluorescein—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000852	CcSEcCtD
Fluorescein—ABCC1—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000161	0.0152	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.00016	0.0152	CbGpPWpGaD
Fluorescein—ABCC1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.015	CbGpPWpGaD
Fluorescein—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00083	CcSEcCtD
Fluorescein—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000155	0.0147	CbGpPWpGaD
Fluorescein—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000818	CcSEcCtD
Fluorescein—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000765	CcSEcCtD
Fluorescein—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000735	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.0131	CbGpPWpGaD
Fluorescein—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.0131	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.0131	CbGpPWpGaD
Fluorescein—Rash—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000729	CcSEcCtD
Fluorescein—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000729	CcSEcCtD
Fluorescein—Headache—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000725	CcSEcCtD
Fluorescein—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000687	CcSEcCtD
Fluorescein—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.0123	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00013	0.0123	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000124	0.0118	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000115	0.0109	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000115	0.0109	CbGpPWpGaD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.0106	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.0105	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000111	0.0105	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.12e-05	0.00864	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.08e-05	0.00861	CbGpPWpGaD
Fluorescein—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	7.49e-05	0.0071	CbGpPWpGaD
Fluorescein—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	7.33e-05	0.00695	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.85e-05	0.00649	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—APIP—chronic obstructive pulmonary disease	6.3e-05	0.00597	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.8e-05	0.0055	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.74e-05	0.00544	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.57e-05	0.00528	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	5.05e-05	0.00479	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.82e-05	0.00457	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.76e-05	0.00451	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	4.73e-05	0.00449	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.72e-05	0.00447	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.49e-05	0.00426	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.0041	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.24e-05	0.00402	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.24e-05	0.00402	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.17e-05	0.00396	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.14e-05	0.00392	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.08e-05	0.00387	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GC—chronic obstructive pulmonary disease	4.06e-05	0.00385	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.04e-05	0.00383	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.04e-05	0.00383	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.02e-05	0.00381	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.97e-05	0.00376	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.78e-05	0.00358	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.7e-05	0.00351	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.65e-05	0.00346	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.38e-05	0.0032	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.14e-05	0.00297	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.11e-05	0.00295	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	3.05e-05	0.00289	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.00285	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3e-05	0.00285	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.84e-05	0.00269	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	2.82e-05	0.00267	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.54e-05	0.00241	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.43e-05	0.00231	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.26e-05	0.00214	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.22e-05	0.0021	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GCLC—chronic obstructive pulmonary disease	2.19e-05	0.00208	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.04e-05	0.00194	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.01e-05	0.00191	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CTGF—chronic obstructive pulmonary disease	2e-05	0.0019	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.87e-05	0.00177	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.85e-05	0.00176	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.00175	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.82e-05	0.00172	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.0016	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	1.67e-05	0.00159	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.67e-05	0.00158	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.65e-05	0.00156	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KL—chronic obstructive pulmonary disease	1.55e-05	0.00147	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.54e-05	0.00146	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.54e-05	0.00146	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.53e-05	0.00145	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.52e-05	0.00144	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.00143	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.46e-05	0.00138	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.00134	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.39e-05	0.00131	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.00127	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	1.17e-05	0.0011	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.0011	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.00108	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.00101	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000954	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.93e-06	0.000941	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.81e-06	0.00093	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	9.72e-06	0.000921	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.15e-06	0.000867	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	9.11e-06	0.000863	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.95e-06	0.000849	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	8.71e-06	0.000826	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.25e-06	0.000782	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	8.18e-06	0.000776	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	7.81e-06	0.000741	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.88e-06	0.000652	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	6.84e-06	0.000648	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.79e-06	0.000643	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.54e-06	0.00062	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.32e-06	0.000599	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	5.17e-06	0.00049	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	5.07e-06	0.00048	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.07e-06	0.000386	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.9e-06	0.000369	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	3.89e-06	0.000369	CbGpPWpGaD
